Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS)

This study has been completed.
Information provided by:
Johnson & Johnson Taiwan Ltd Identifier:
First received: April 13, 2007
Last updated: April 26, 2010
Last verified: April 2010